Literature DB >> 32894619

Differential effects of integrase strand transfer inhibitors, elvitegravir and raltegravir, on oligodendrocyte maturation: A role for the integrated stress response.

Lindsay M Roth1,2, Bassam Zidane1,2,3, Lindsay Festa1,2, Raj Putatunda1, Micah Romer1, Hubert Monnerie1, Kelly L Jordan-Sciutto2, Judith B Grinspan1.   

Abstract

Regardless of adherence to combined antiretroviral therapy, white matter and myelin pathologies persist in patients with HIV-associated neurocognitive disorders, a spectrum of cognitive, motor, and behavioral impairments. We hypothesized that antiretroviral therapy alters the maturation of oligodendrocytes which synthesize myelin. We tested whether specific frontline integrase strand transfer inhibitors would alter oligodendrocyte differentiation and myelination. To model the effect of antiretrovirals on oligodendrocytes, we stimulated primary rat oligodendrocyte precursor cells to differentiate into mature oligodendrocytes in vitro in the presence of therapeutically relevant concentrations of elvitegravir or raltegravir and then assessed differentiation with lineage specific markers. To examine the effect of antiretrovirals on myelination, we treated mice with the demyelinating compound cuprizone, for 5 weeks. This was followed by 3 weeks of recovery in absence of cuprizone, during which time some mice received a daily intrajugular injection of elvitegravir. Brains were harvested, sectioned and processed by immunohistochemistry to examine oligodendrocyte maturation and myelination. Elvitegravir inhibited oligodendrocyte differentiation in vitro in a concentration-dependent manner, while raltegravir had no effect. Following cuprizone demyelination, administration of elvitegravir to adult mice reduced remyelination compared with control animals. Elvitegravir treatment activated the integrated stress response in oligodendrocytes in vitro, an effect which was completely blocked by pretreatment with the integrated stress response inhibitor Trans-ISRIB, preventing elvitegravir-mediated inhibition of oligodendrocyte maturation. These studies demonstrate that elvitegravir impairs oligodendrocyte maturation and remyelination and that the integrated stress response mediates this effect and may be a possible therapeutic target.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  HAND; HIV; integrated stress response; myelin; neuroinflammation; oligodendrocytes

Mesh:

Substances:

Year:  2020        PMID: 32894619      PMCID: PMC7736549          DOI: 10.1002/glia.23902

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  43 in total

1.  Determinants of conduction velocity in myelinated nerve fibers.

Authors:  S G Waxman
Journal:  Muscle Nerve       Date:  1980 Mar-Apr       Impact factor: 3.217

2.  White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study.

Authors:  N Pomara; D T Crandall; S J Choi; G Johnson; K O Lim
Journal:  Psychiatry Res       Date:  2001-02-28       Impact factor: 3.222

3.  Differential Effects of Antiretroviral Drugs on Neurons In Vitro: Roles for Oxidative Stress and Integrated Stress Response.

Authors:  Anna L Stern; Rebecca N Lee; Nina Panvelker; Jiean Li; Jenna Harowitz; Kelly L Jordan-Sciutto; Cagla Akay-Espinoza
Journal:  J Neuroimmune Pharmacol       Date:  2017-08-31       Impact factor: 4.147

Review 4.  Neurotoxicity in the Post-HAART Era: Caution for the Antiretroviral Therapeutics.

Authors:  Ankit Shah; Mohitkumar R Gangwani; Nitish S Chaudhari; Alexy Glazyrin; Hari K Bhat; Anil Kumar
Journal:  Neurotox Res       Date:  2016-06-30       Impact factor: 3.911

5.  Immunohistochemical localization of aspartoacylase in the rat central nervous system.

Authors:  Chikkathur N Madhavarao; John R Moffett; Roger A Moore; Ronald E Viola; M A Aryan Namboodiri; David M Jacobowitz
Journal:  J Comp Neurol       Date:  2004-05-03       Impact factor: 3.215

6.  Expression of the endoplasmic reticulum stress response marker, BiP, in the central nervous system of HIV-positive individuals.

Authors:  K A Lindl; C Akay; Y Wang; M G White; K L Jordan-Sciutto
Journal:  Neuropathol Appl Neurobiol       Date:  2007-10-11       Impact factor: 8.090

7.  Protease Inhibitors, Saquinavir and Darunavir, Inhibit Oligodendrocyte Maturation: Implications for Lysosomal Stress.

Authors:  Lindsay Festa; Lindsay M Roth; Brigid K Jensen; Jonathan D Geiger; Kelly L Jordan-Sciutto; Judith B Grinspan
Journal:  J Neuroimmune Pharmacol       Date:  2019-11-28       Impact factor: 4.147

8.  Activation status of integrated stress response pathways in neurones and astrocytes of HIV-associated neurocognitive disorders (HAND) cortex.

Authors:  C Akay; K A Lindl; N Shyam; B Nabet; Y Goenaga-Vazquez; J Ruzbarsky; Y Wang; D L Kolson; K L Jordan-Sciutto
Journal:  Neuropathol Appl Neurobiol       Date:  2012-04       Impact factor: 8.090

9.  The small molecule ISRIB reverses the effects of eIF2α phosphorylation on translation and stress granule assembly.

Authors:  Carmela Sidrauski; Anna M McGeachy; Nicholas T Ingolia; Peter Walter
Journal:  Elife       Date:  2015-02-26       Impact factor: 8.140

Review 10.  Integrated Stress Response as a Therapeutic Target for CNS Injuries.

Authors:  Lorenzo Romero-Ramírez; Manuel Nieto-Sampedro; M Asunción Barreda-Manso
Journal:  Biomed Res Int       Date:  2017-04-27       Impact factor: 3.411

View more
  3 in total

Review 1.  Applications of Brain Organoids for Infectious Diseases.

Authors:  Wenqiang Fan; Kimberly M Christian; Hongjun Song; Guo-Li Ming
Journal:  J Mol Biol       Date:  2021-09-15       Impact factor: 5.469

Review 2.  Beyond Myelination: Possible Roles of the Immune Proteasome in Oligodendroglial Homeostasis and Dysfunction.

Authors:  Miguel M Madeira; Zachary Hage; Stella E Tsirka
Journal:  Front Neurosci       Date:  2022-05-09       Impact factor: 5.152

3.  HIV-induced neuroinflammation inhibits oligodendrocyte maturation via glutamate-dependent activation of the PERK arm of the integrated stress response.

Authors:  Lindsay M Roth; Cagla Akay-Espinoza; Judith B Grinspan; Kelly L Jordan-Sciutto
Journal:  Glia       Date:  2021-05-31       Impact factor: 8.073

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.